Picture EBD Group World of Partnering Opportunities 650x100px

News > All

Total search results: 3657 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 9 10 11 ... 35 36 37  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Immunic, Inc.. (10/10/22). "Press Release: Immunic, Inc. Announces $60.0 Million Oversubscribed Private Placement Equity Financing". New York, NY. 2022-10-10
IZB Martinsried. (10/7/22). "Press Release: Munich Life Science Pitch Day at the IZB. Eleven Teams Presented to 28 Life Science Investors with an Available Investment Volume of more than 20 Billion Euros". Martinsried. 2022-10-07
ArchiMed SAS. (10/7/22). "Press Release: ArchiMed Invests in PlasmidFactory, a German Gene and Cell Therapy Specialist". 2022-10-07
High-Tech Gründerfonds Management GmbH. (10/6/22). "Press Release: Real-Time Monitoring of Bioprocesses. Irubis Closes EUR 2.8m Seed Round Led by HTGF, Verve Ventures and Ventura BioMed Investors". Munich. 2022-10-06
T-Curx GmbH. (10/6/22). "Press Release: T-Curx GmbH, a German CAR-T Cell Biotech Spin-Off from University of Würzburg, Appoints Ulf Grawunder as CEO". Würzburg. 2022-10-06
Terraplasma GmbH. (10/6/22). "Press Release: Election of an Advisory Board for Terraplasma. Extensive Industry Expertise". Garching. 2022-10-06 AG. (10/5/22). "Press Release: Collaborates with Boehringer Ingelheim to Investigate Cardiac Organoids for the Development of New Treatments for People with Heart Diseases". Vienna. 2022-10-05
BioRiver – Life Science im Rheinland e.V.. (10/5/22). "Press Release: Three Disruptive Approaches in Biotechnology and Medicine Win the BioRiver Boost! 2022 Biotech Start-up Competition". Düsseldorf & Hilden. 2022-10-05
Araris Biotech AG. (10/4/22). "Press Release: Araris Biotech Closes $24 Million Financing Round". Zurich. 2022-10-04
Aurobac Therapeutics SAS. (10/4/22). "Press Release: Aurobac Therapeutics, the Joint Venture Recently Created by Boehringer Ingelheim, Evotec and bioMérieux, Appoints Florence Séjourné as Chief Executive Officer". Lyon. 2022-10-04
Sibylla Biotech S.p.A.. (10/4/22). "Press Release: Sibylla Biotech Raises €23 Million Series A to Advance Protein Degradation by Folding Interference Pipeline and Expand Technology Platform". Verona. 2022-10-04
Valneva S.E.. (10/4/22). "Press Release: Valneva Announces Closing of Upsized €102.9 Million Global Offering". Saint-Herblain. 2022-10-04
BioM Biotech Cluster Development GmbH. (9/30/22). "Press Release: Prof. Ralf Huss Appointed as New Managing Director of BioM Biotech Cluster Development GmbH". 2022-09-30
Sartorius AG. (9/30/22). "Press Release: Sartorius Completes Acquisition of Albumedix". Göttingen. 2022-09-30
Xund Solutions GmbH. (9/29/22). "Press Release: Healthtech Start-up Xund Raises €6m – One of the Largest Seed Rounds to Date in Austria". 2022-09-29
Assay.Works GmbH. (9/29/22). "Press Release: Partex Welcomes Assay.Works to Its Digital Pharma Platform". Eschborn & Regensburg. 2022-09-29
Pureos Partners AG. (9/28/22). "Press Release: Pureos Partners Welcomes Dr. Veronica Gambillara Fonck as New Partner to Its Investment Team". Pfäffikon. 2022-09-28
High-Tech Gründerfonds Management GmbH. (9/28/22). "Press Release: GS Bavaria Closes Seven-figure Seed Round for Scaling Tungsten Particles as Sustainable Additive in Composites". 2022-09-28
BRAIN Biotech AG. (9/27/22). "Press Release: Change in the Executive Management Board of BRAIN Biotech AG, Genome Editing Activities Established Under the Akribion Genomics brand". Zwingenberg. 2022-09-27
NLC Ventures Netherlands B.V.. (9/27/22). "Press Release: BioDGraft, an NLC Venture, Sets Out to Eliminate the Need for Vein Harvesting in Bypass Surgeries, Proposing a Solution that Lasts for Life". 2022-09-27
Arsenal Biosciences, Inc.. (9/27/22). "Press Release: Arsenal Biosciences Announces Joint Discovery Collaboration with Genentech to Identify Features of Successful T-Cell Therapies for Oncology". South San Francisco, CA. 2022-09-27
Navigo Proteins GmbH. (9/26/22). "Press Release: Navigo and Mannin Sign Agreement to Develop Innovative Affinity Ligand Against a Novel Drug for the Treatment of COVID-19". Halle (Saale). 2022-09-26
Kupando GmbH. (9/26/22). "Press Release: Kupando Raises €13 Million in Series A Funding Round". Schönefeld. 2022-09-26
Catalym GmbH. (9/26/22). "Press Release: Catalym Receives FDA IND Clearance to Expand Development of Visugromab in Advanced Cancer Patients into the U.S.". Munich. 2022-09-26
c-LEcta GmbH. (9/23/22). "Press Release: OFB Starts Construction Work for »BioSquare Leipzig« Technology Campus". 2022-09-23
Biovian Oy. (9/22/22). "Press Release: Biovian Announces the Appointment of a New Board Member. Dr. Uwe Gottschalk Has Joined Biovian’s Board of Directors". 2022-09-22
Adapsyn Bioscience Inc.. (9/21/22). "Press Release: Adapsyn Bioscience Enters into Strategic Collaboration with Evotec". Hamilton, ON. 2022-09-21
Merck KGaA. (9/21/22). "Press Release: Merck Opens New € 29 Million Biologics Testing Center in Shanghai". Shanghai. 2022-09-21
Merck KGaA. (9/21/22). "Press Release: Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor [ Not intended for US- or Canada- and UK-based media ]". Darmstadt. 2022-09-21
Hedera Dx S.A.. (9/21/22). "Press Release: Hedera Dx Raises €14 Million in Seed Funding to Accelerate Global Adoption of Liquid Biopsies". Lausanne. 2022-09-21
ECBF Management GmbH. (9/20/22). "Press Release: ECBF Leads €10m Series B Investment in Digital Pest Monitoring Provider Trapview to Expand Its Sustainable Agriculture Technology Portfolio". Luxembourg. 2022-09-20
Nuvisan ICB GmbH. (9/20/22). "Press Release: Nuvisan Receives US$ 9.6m Grant for a Multi-target Drug Discovery Program on Novel Non-hormonal Contraceptive Medicines". Berlin. 2022-09-20
Evotec SE. (9/20/22). "Press Release: Just – Evotec Biologics Awarded Contract from the U.S. Department of Defense under Accelerated Antibodies Program". Hamburg. 2022-09-20
Avelo AG. (9/20/22). "Press Release: Avelo Closes CHF 2.2 Million Oversubscribed Seed Round". 2022-09-20
Scailyte AG. (9/19/22). "Press Release: Scailyte Closes Series A Funding with a CHF 6 Million Investment". 2022-09-19
Genfit S.A.. (9/19/22). "Press Release: Genfit to Acquire Clinical-stage Biopharmaceutical Company Versantis, Expanding Its Portfolio in Liver Diseases". Lille & Cambridge, MA. 2022-09-19
Evotec SE. (9/16/22). "Press Release: Evotec Initiates Ground-breaking for New Biologics Facility J.POD Toulouse, France (EU)". Hamburg. 2022-09-16
Eppendorf SE. (9/16/22). "Press Release: Eppendorf Expands High-tech Site in Jülich and Celebrates Topping-out Ceremony for Multifunctional Building". Jülich & Hamburg. 2022-09-16
Tricares SAS. (9/15/22). "Press Release: Tricares Raises €47m in a First Closing of Its Series C Financing to Fund Further Development of Minimally Invasive Treatment for Tricuspid Regurgitation". Paris & Munich. 2022-09-15
Aignostics GmbH. (9/15/22). "Press Release: Aignostics Raises €14m Series A to Advance AI-powered Pathology". Berlin. 2022-09-15
Forever Healthy Foundation gGmbH. (9/15/22). "Press Release: Rejuvenation Startup Summit 2022 Announces Program and Speakers". 2022-09-15
Tridek-One SAS. (9/15/22). "Press Release: Tridek-One Closes a €16 Million Financing Round to Develop First-in-Class Immune Checkpoint Agonists". Paris. 2022-09-15
Kuros Biosciences AG. (9/15/22). "Press Release: Kuros Biosciences Announces Successful CHF 6.0 Million Private Placement (Ad-hoc announcement pursuant to Article 53 of the SIX listing rules)". Schlieren. 2022-09-15
T-Curx GmbH. (9/15/22). "Press Release: Caroline Burger, PhD, Appointed as T-Curx' Global Head Business Development". Würzburg. 2022-09-15
Capstan Therapeutics, Inc.. (9/14/22). "Press Release: Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering". San Diego, CA & Philadelphia, PA. 2022-09-14
Scienion AG. (9/13/22). "Press Release: Scienion and Cellenion Launch the proteoCHIP LF 48, for Label-free Single-cell Proteomics Sample Preparation on the cellenONE platform". Berlin & Lyon. 2022-09-13 AG. (9/12/22). "Press Release: and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA. 2022-09-12
Precirix N.V.. (9/12/22). "Press Release: Precirix Enters into Collaboration with Eckert & Ziegler for the Development of Its 68Ga-based Compounds". Brussels & Berlin. 2022-09-12
Immatics N.V.. (9/10/22). "Press Release: Immatics Presents Comprehensive Preclinical Data Set for TCR Bispecific Candidate IMA402 Targeting PRAME at European Society for Medical Oncology (ESMO) Congress 2022". Houston, TX & Tübingen. 2022-09-10
Heidelberg Pharma AG. (9/9/22). "Press Release: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate". Ladenburg. 2022-09-09
genOway S.A.. (9/8/22). "Press Release: Sigma-Aldrich and genOway Expand Their CRISPR/Cas9 Strategic Alliance". St. Louis, MO & Lyon. 2022-09-08
faCelliate GmbH. (9/7/22). "Press Release: faCellitate, a BASF Spin-off, Closes a €3.7m Seed Round Led by Sarstedt and HTGF". Mannheim. 2022-09-07
Indivumed GmbH. (9/7/22). "Press Release: Indivumed and CellPhenomics Announce Partnership for Improved Cancer Patient Care". Berlin & Hamburg. 2022-09-07
QLi5 Therapeutics GmbH. (9/7/22). "Press Release: QLi5 Therapeutics Attracts EUR 10 Million in Series A Financing". Dortmund. 2022-09-07
Biosynth AG. (9/7/22). "Press Release: Biosynth Carbosynth, Vivitide and Pepscan Rebrand to Biosynth". Staad. 2022-09-07
PhoreMost Ltd.. (9/6/22). "Press Release: PhoreMost Enters Multi-project Drug Target Discovery Collaboration with Roche". Cambridge. 2022-09-06
ADC Therapeutics S.A.. (9/6/22). "Press Release: ADC Therapeutics to Participate in Morgan Stanley’s 20th Annual Global Healthcare Conference". Lausanne. 2022-09-06
EMBL. (9/6/22). "Press Release: ERC Proof-of-Concept Grant Provides Way to Realise Commercial Potential of ‘SpaceM’ Technology". 2022-09-06
Emergence Therapeutics AG. (9/6/22). "Press Release: Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal". Amsterdam & Duisburg. 2022-09-06
Nodus Oncology Ltd.. (9/6/22). "Press Release: Nodus Oncology Launches, Founded by Cumulus Oncology and in Partnership with the Lead Discovery Center, to Focus on Developing First and Best-in-Class Molecules Inhibiting Novel DNA Damage Response Targets". 2022-09-06
Nodus Oncology Ltd.. (9/6/22). "Press Release: Nodus Oncology Announces Acquisition of Basilea Pharmaceutica’s PARG Inhibitor Programme". Edinburgh. 2022-09-06
Arcensus GmbH. (9/5/22). "Press Release: Dammam Valley/KSA to Acquire the Majority of Arcensus GmbH/Germany to Accelerate the Global implementation of Whole Genome Sequencing in Genetic Diagnostics and Delivery of Breakthrough Technologies in Genomic Bio 2022-09-05
Boehringer Ingelheim. (9/2/22). "Press Release: U.S. FDA Approves First Treatment Option for Generalized Pustular Psoriasis Flares in Adults". Ingelheim. 2022-09-02
BioEcho Life Sciences GmbH. (9/2/22). "Press Release: BioEcho Life Sciences Announces Expansion with New US Subsidiary". Cologne. 2022-09-02
Ginkgo Bioworks Inc.. (9/1/22). "Press Release: Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manufacturing and Life Science Tools". Boston, MA. 2022-09-01
C-mo Medical Solutions. (9/1/22). "Press Release: C-mo Medical Solutions Raises €4.1 Million Aiming to Transform Cough Monitoring". Lisbon. 2022-09-01
AiCuris Anti-infective Cures AG. (9/1/22). "Press Release: AiCuris Appoints Experienced Business Leader Dr. Sabrina Kuttruff-Coqui as Chief Financial Officer". Wuppertal. 2022-09-01
Agilent Technologies Inc.. (9/1/22). "Press Release: Agilent Collaborates with Mettler Toledo to Reduce Errors in Sample Preparation Workflows for Better Chromatographic Results". Santa Clara, CA. 2022-09-01
Carbios S.A.. (9/1/22). "Press Release: Carbios Strengthens Executive Committee with the Appointment of Pascal Bricout as Chief Strategy & Financial Officer". Clermont-Ferrand. 2022-09-01
Dynamic Biosensors GmbH. (9/1/22). "Press Release: 2bind and Dynamic Biosensors Sign Technology-Service Partnership". Munich & Regensburg. 2022-09-01
Novartis AG. (9/1/22). "Press Release: Novartis Appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., Steps Down from the Executive Committee of Novartis". Basel. 2022-09-01
Affimed N.V.. (9/1/22). "Press Release: Affimed to Present at Upcoming Investor Conferences". Heidelberg. 2022-09-01
BioNTech SE. (9/1/22). "Press Release: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union". New York, NY & Mainz. 2022-09-01
Centogene N.V.. (9/1/22). "Press Release: Centogene to Present at Upcoming Investor & Partnering Conferences in September". Cambridge, MA, Rostock & Berlin. 2022-09-01
InfanDx AG. (9/1/22). "Press Release: InfanDx AG Appoints Nicole Witzmann as Chief Financial Officer". Cologne, Berlin & Boston, MA. 2022-09-01
Life Science Valley GmbH. (9/22). "Pressemitteilung: Life Science Valley erhält Projektförderung vom Land Niedersachsen". 2022-09-01
MorphoSys AG. (8/31/22). "Press Release: MorphoSys Appoints Tim Demuth as New Chief Research and Development Officer, Following the Retirement of Malte Peters". Planegg. 2022-08-31
BioNTech SE. (8/31/22). "Press Release: Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older". New York, NY & Mainz. 2022-08-31
CRISPR Therapeutics AG. (8/31/22). "Press Release: CRISPR Therapeutics to Participate in Upcoming Investor Conferences". Zug & Cambridge, MA. 2022-08-31
Heidelberg Pharma AG. (8/30/22). "Press Release: Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure [ Not for US, CA, et al.]". Ladenburg. 2022-08-30
Formycon AG. (8/29/22). "Press Release: European Commission Approves FYB201/Ranivisio (Ranivisio - Ranibizumab), a Biosimilar to Lucentis". Munich, Amsterdam & Zug. 2022-08-29
Moderna, Inc.. (8/26/22). "Press Release: Moderna Sues Pfizer and BioNTech for Infringing Patents Central to Moderna's Innovative mRNA Technology Platform". Cambridge, MA. 2022-08-26
Evotec SE. (8/25/22). "Press Release: Evotec Expands Clinical and Commercial Drug Substance Manufacturing with Acquisition of Central Glass Germany". Hamburg. 2022-08-25
Novartis AG. (8/25/22). "Press Release: Novartis Announces Intention to Separate Sandoz Business to Create a Standalone Company by Way of a 100% Spin-off". Basel. 2022-08-25
Oncgnostics GmbH. (8/25/22). "Press Release: German Oncgnostics GmbH‘s Innovation in the Area of Cervical Cancer Diagnostics Now also Available in China". Jena. 2022-08-25
Roche. (8/23/22). "Press Release: Roche Launches a Digital PCR System, a Powerful New Diagnostics Platform in the Fight against Cancer and other Diseases". Basel. 2022-08-23
Evolva Holding S.A.. (8/23/22). "Press Release: Evolva Statement to SER Communication. Evolva Takes Note of the Sanction Request Submitted by SIX Exchange Regulation (SER) Today". Reinach. 2022-08-23
Immatics N.V.. (8/23/22). "Press Release: Immatics Announces First Cancer Patient Treated with Second-generation ACTengine TCR-T Candidate IMA203CD8 Targeting PRAME". Houston, TX & Tübingen. 2022-08-23
BioNTech SE. (8/22/22). "Press Release: Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine". New York, NY & Mainz. 2022-08-22
Vaderis Therapeutics AG. (8/22/22). "Press Release: Vaderis Therapeutics AG Emerges from Stealth and Announces Initiation of Clinical Proof-of-Concept Trial in HHT". Basel. 2022-08-22
BioInnovation Institute (BII). (8/22/22). "Press Release: BII Supports Three International Start-ups Developing Pioneering Science in the Therapeutics and Health Tech Space". 2022-08-22
Kinarus Therapeutics Holding AG. (8/22/22). "Press Release: Kinarus Announces the Issuance of Convertible Notes of up to CHF 20 Million to an Entity Managed by Yorkville [ not for any jurisdiction where unlawful]". Basel. 2022-08-22
HMNC Holding GmbH. (8/22/22). "Press Release: Maximilian Doebler Appointed Chief Business Officer of HMNC Brain Health". Munich. 2022-08-22
Valneva S.E.. (8/18/22). "Press Release: Valneva Provides Update on Ixiaro Supply Contract with U.S. Department of Defense". Saint-Herblain. 2022-08-18
Rentschler Biopharma SE. (8/18/22). "Press Release: Rentschler Biopharma Appoints Mark Caswell as Vice President, Site Head for US Facility". Laupheim & Milford, MA. 2022-08-18
SHS Gesellschaft für Beteiligungsmanagement mbH. (8/18/22). "Press Release: SHS Appoints Manfred Ulmer-Weber to the Management Board". Tübingen. 2022-08-18
ADC Therapeutics S.A.. (8/15/22). "Press Release: ADC Therapeutics Announces $175 Million Senior Secured Term Loan from Owl Rock and Oaktree and Settlement of Existing Senior Secured Convertible Notes". Lausanne. 2022-08-15
Medicines Discovery Catapult (MDC). (8/11/22). "Press Release: Medicines Discovery Catapult and Zeiss Set Sights on Advancing Microscopy. Driving the Application of Microscopy in Drug Discovery". 2022-08-11
ChemDiv, Inc.. (8/11/22). "Press Release: ChemDiv and Jacobs University Announce Strategic Partnership in Drug Discovery". San Diego, CA & Bremen. 2022-08-11
Rentschler Biopharma SE. (8/10/22). "Press Release: Rentschler Biopharma Expands Leadership Team with Senior-level Hires". Laupheim. 2022-08-10
next pagenext page 1 2 3 ... 9 10 11 ... 35 36 37  next pagenext page


Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group World of Partnering Opportunities 650x300px

» top